Complete Filing Data
Intercure Ltd. reported Cash And Cash Equivalents of $78.32 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Intercure Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Profit Loss | -$72.8M | -$63.5M | $43.7M | $7.3M | -$36.0M | -$5.9M |
| Sales And Marketing Expense | $54.2M | $53.3M | $56.5M | $23.2M | $8.4M | $2.7M |
| Research And Development Expense | $414.0K | $388.0K | $632.0K | $1.2M | $1.6M | $1.7M |
| Profit Loss From Operating Activities | -$67.2M | -$41.6M | $50.6M | $28.2M | -$38.4M | -$3.4M |
| Profit Loss Before Tax | -$87.3M | -$61.3M | $43.8M | $18.7M | -$38.3M | -$6.6M |
| Profit Loss Attributable To Owners Of Parent | -$67.8M | -$62.0M | $44.8M | $4.7M | -$37.2M | -$5.9M |
| Income Tax Expense Continuing Operations | -$14.5M | $2.2M | $93.0K | $11.4M | -$2.3M | -$673.0K |
| Gross Profit | $30.2M | $105.1M | $155.1M | $91.1M | $32.0M | $1.5M |
| General And Administrative Expense | $53.7M | $42.6M | $36.1M | $27.2M | $8.6M | $12.1M |
| Cost Of Sales | $203.3M | $247.2M | $229.7M | $123.7M | $34.6M | $7.5M |
| Adjustments Of Comprehensive Income Net | $27.9M | $108.7M | $18.5M | $36.3M | $48.1M | -$8.0M |
| Adjustments For Reconcile Profit Loss | $18.8M | $17.5M | $15.5M | $34.6M | $43.9M | -$5.6M |
| Profit Loss Attributable To Noncontrolling Interests | -$5.0M | -$1.6M | -$1.1M | $2.6M | $1.2M | |
| Income Taxes Paid Refund Classified As Operating Activities | $12.9M | $7.6M | $8.0M | $11.8M | $50.0K | |
| Profit Loss From Fair Value Changes Realized In Current Year | -$11.8M | -$3.5M | -$16.9M | -$11.4M | -$1.6M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $78.3M | $101.1M | $232.6M | $196.2M | $37.9M | $27.3M | $3.4M |
| Unrealized Changes To Fair Value Adjustments Of Biological Assets | $6.5M | $261.0K | $13.1M | $6.6M | $3.2M | $3.1M | |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $4.4M | $2.6M | $19.7M | $14.0M | $20.8M | $28.1M | |
| Gains Losses On Financial Assets At Fair Value Through Profit Or Loss | $341.0K | -$665.0K | -$174.0K | -$1.9M | -$37.2M | -$21.0M | |
| Changes In Increase In Other Payables | $3.9M | $4.7M | -$812.0K | $9.4M | $4.3M | $1.9M | |
| Changes In Biological Assets | -$4.2M | $5.5M | -$799.0K | -$2.4M | -$2.0M | -$1.1M | |
| Changes In Assets And Liabilities Net | -$9.2M | -$91.2M | -$3.0M | -$1.7M | -$4.1M | $2.4M | |
| Cash Flows From Used In Operating Activities | -$66.9M | -$53.6M | $51.3M | $30.1M | $7.9M | -$11.6M | |
| Cash Flows From Used In Investing Activities | $17.7M | $4.8M | -$142.5M | -$65.2M | -$22.8M | -$26.1M | |
| Cash Flows From Used In Financing Activities | $26.5M | -$82.9M | $120.4M | $197.9M | $25.2M | $63.2M | |
| Biological Assets | $5.0M | $822.0K | $6.4M | $5.6M | $3.2M | $1.1M | |
| Adjustments In Gains Losses On Financial Assets At Fair Value Through Profit Or Loss | -$371.0K | $661.0K | $172.0K | $1.9M | $37.2M | -$21.0M | |
| Adjustments For Increase Decrease In Trade And Other Payables | -$8.9M | -$47.6M | $57.0M | $2.8M | $12.3M | $4.0M | |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | $132.0K | -$184.0K | $418.0K | -$314.0K | -$39.0K | $96.0K | |
| Adjustments For Deferred Tax Expense | -$14.5M | $2.2M | $93.0K | $11.4M | -$2.3M | -$673.0K | |
| Adjustments For Decrease Increase In Trade And Other Receivables | $8.4M | -$23.5M | -$18.3M | $8.4M | -$9.6M | -$1.2M | |
| Adjustments For Decrease Increase In Other Operating Receivables | $4.8M | -$64.9M | $35.0M | -$4.3M | $5.1M | -$4.2M | |
| Aggregate Result Of Acquisition Trade And Other Receivables | $3.3M | -$1.9M | $20.9M | $20.9M | $1.8M | $1.1M | |
| Aggregate Result Of Acquisition Trade And Other Payables | $13.6M | -$7.9M | $51.1M | $51.1M | $1.9M | $1.7M | |
| Aggregate Result Of Acquisition Property Plant Equipment And Rightofuse Asset | $10.2M | -$1.9M | $6.3M | $6.3M | $3.2M | $1.8M | |
| Aggregate Result Of Acquisition Of Subsidiary Net Of Cash | -$1.1M | $1.6M | -$19.1M | -$19.1M | -$387.0K | -$385.0K | |
| Aggregate Result Of Acquisition Inventory And Biological Assets | $2.6M | -$2.6M | $22.8M | $22.8M | $237.0K | $7.7M | |
| Aggregate Result Of Acquisition Goodwill | $7.9M | -$15.9M | $68.0M | $68.0M | $22.1M | $168.0M | |
| Liabilities | $364.9M | $329.6M | $436.5M | $227.1M | $34.2M | -$26.0M | |
| Goodwill | $224.6M | $221.1M | $284.2M | $268.3M | $190.1M | ||
| Cash Advances And Loans Granted To Other Parties Classified As Investing Activities | $928.0K | $5.2M | $95.2M | $7.3M | $1.6M | ||
| Assets | $762.6M | $786.6M | $958.0M | $696.5M | $326.3M | $282.2M | |
| Trade Receivables | $51.8M | $60.4M | $36.9M | $17.4M | $12.5M | ||
| Trade And Other Current Payables To Trade Suppliers | $77.5M | $78.4M | $126.1M | $64.5M | $18.6M | ||
| Retained Earnings | -$277.6M | -$204.0M | -$141.6M | -$186.5M | -$191.2M | ||
| Other Receivables | $134.7M | $141.1M | $97.4M | $33.2M | $3.7M | ||
| Other Current Financial Liabilities | $41.8M | $55.2M | $48.4M | $41.1M | $9.4M | ||
| Noncurrent Liabilities | $138.2M | $103.7M | $123.8M | $33.5M | $4.3M | ||
| Noncurrent Lease Liabilities | $23.2M | $20.6M | $23.1M | $21.4M | $3.5M | ||
| Noncurrent Financial Assets At Fair Value Through Profit Or Loss | $333.0K | $187.0K | $2.6M | $2.6M | $3.1M | ||
| Noncurrent Assets | $370.8M | $367.8M | $410.5M | $360.4M | $249.6M | ||
| Equity Attributable To Owners Of Parent | $397.0M | $455.1M | $501.3M | $448.0M | $274.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Payments Of Lease Liabilities Classified As Financing Activities | $5.5M | $4.7M | $3.9M | $2.6M | $576.0K | $189.0K |
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | -$22.8M | -$131.7M | $29.2M | $162.9M | $10.3M | $25.6M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$39.0K | $297.0K | $7.2M | -$4.5M | $221.0K | -$1.7M |
| Proceeds From Borrowings Classified As Financing Activities | $188.4M | $62.7M | $263.5M | $75.5M | $665.0K | |
| Payments Of Contingent Consideration | $4.2M | $6.2M | $3.5M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $-1.48 | $-1.36 | $0.99 | $0.11 | $-1.42 | $-0.25 |
| Basic Earnings Loss Per Share | $-1.48 | $-1.36 | $0.99 | $0.12 | $-1.42 | $-0.25 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Other Operating Income Expense | $12.8M | -$47.1M | -$2.1M | -$3.0M | -$4.6M | -$59.0M |
| Increase Decrease Through Sharebased Payment Transactions | $2.3M | $2.6M | $8.9M | $6.5M | $10.5M | $68.0M |
| Gross Income Before Impact Of Changes In Fair Value | $35.6M | $108.3M | $159.0M | $96.0M | $30.4M | $1.5M |
| Financing Expenses | $22.9M | $25.6M | $15.0M | $9.6M | $528.0K | $3.3M |
| Finance Income Cost | -$20.1M | -$19.7M | -$6.8M | -$9.5M | $92.0K | -$3.2M |
| Finance Income | $2.7M | $5.9M | $8.2M | $130.0K | $620.0K | $141.0K |
| Adjustments For Sharebased Payments | $2.3M | $2.6M | $8.9M | $6.5M | $10.0M | $68.0M |
| Adjustments For Depreciation And Amortisation Expense | $15.4M | $13.2M | $11.7M | $7.4M | $3.3M | $828.0K |
| Adjustments For Decrease Increase In Inventories | -$13.2M | $34.7M | -$75.2M | -$15.5M | -$14.2M | $3.0M |
| Repayments Of Bonds Notes And Debentures | $76.0K | $1.3M | $3.6M | $13.8M | $143.0K | |
| Repayments Of Borrowings Classified As Financing Activities | $175.2M | $119.9M | $120.5M | $3.4M | $174.0K | |
| Aggregate Result Of Acquisition Short Term Loan | -$198.0K | -$4.3M | $4.3M | $4.3M | $1.3M | $2.1M |
| Interest Paid Classified As Financing Activities | $15.2M | $20.9M | $17.3M | $5.1M | $93.0K | |
| Shortterm Borrowings | $69.4M | $88.2M | $126.9M | $70.6M | $357.0K | |
| Noncurrent Provisions For Employee Benefits | $973.0K | $841.0K | $1.0M | $224.0K | $155.0K | |
| Noncontrolling Interests | $702.0K | $2.0M | $20.2M | $21.4M | $17.6M | |
| Longterm Borrowings | $114.0M | $82.2M | $99.7M | $11.9M | $388.0K | |
| Issued Capital | $658.6M | $643.2M | $632.0M | $623.6M | $452.3M | |
| Inventories | $120.3M | $105.5M | $140.1M | $62.3M | $19.0M |
Most recent annual filing with the SEC: May 1, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.